본문 바로가기

Elevation of the Plasma A beta(40)/A beta(42) Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
JOURNAL OF ALZHEIMERS DISEASE48(4) · pp.1043 · 2015
피인용
Web of Science 37
JCR IF
JCR 2014 4.151
ISSN
1387-2877

저자

  1. Kim, Hyeong Jun제1저자Department of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
  2. Park, Kyung WonDepartment of Neurology, Dong-A University College of Medicine, Dong-A University Hospital, Busan, South Korea
  3. Kim, Tae EunDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
  4. Im, Ji YoungDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
  5. Shin, Ho SikDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
  6. Kim, SaeromiDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
  7. Lee, Dong HyunDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
  8. Ye, Byoung SeokDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
  9. Kim, Jong HunDepartment of Neurology, Ilsan Hospital, National Health Insurance Corporation, Goyang, South Korea
  10. 김은주Department of Neurology, Pusan National University Hospital, Busan, South Korea
  11. Park, Kee HyungDepartment of Neurology, Gachon University, College of Medicine, Incheon, South Korea
  12. Han, Hyun JeongDepartment of Neurology, Myongii Hospital, Seonam University, Goyang, South Korea
  13. Jeong, Jee HyangDepartment of Neurology, Ewha Womans University, Mokdong Hospital, Seoul, South Korea
  14. Choi, Seong HyeDepartment of Neurology, Inha University, School of Medicine, Incheon, South Korea
  15. Park, Sun Ah교신저자Department of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea

초록

Background: Although plasma amyloid-beta (A beta) levels have been evaluated as a possible diagnostic marker of Alzheimer's disease (AD), the findings are inconsistent. Objective: The present study aimed to validate plasma levels of A beta(40), A beta(42), and the A beta(40)/A beta(42) ratio as biomarkers of AD in subjects with early-onset AD (EOAD) without familial AD genetic mutations. Methods: Patients with sporadic EOAD (sEOAD) were prospectively recruited by nine neurology clinics. Plasma levels of A beta(40) and A beta(42) were measured using a sandwich enzyme-linked immunosorbent assay (ELISA) in 100 sEOAD (50-69 year-old) and 46 age-matched normal control subjects (50-72 year-old). Cerebrospinal fluid (CSF) was obtained from 32 sEOAD subjects and 25 controls. The integrity of the blood-brain barrier was assessed using the CSF/plasma albumin ratio. Results: The plasma levels of A beta(42) were significantly lower, while the A beta(40)/A beta(42) ratio was significantly higher in sEOAD patients than in controls. The levels of A beta(40), A beta(42), and the A beta(40)/A beta(42) ratio did not differ in relation to the APOE epsilon 4 allele. The CSF/plasma albumin ratio was comparable between the two groups, and the plasma parameters of A beta proteins were not significantly associated. A multivariate analysis revealed that an increased A beta(40)/A beta(42) ratio is valuable for the discrimination of sEOAD from controls (beta = 0.344, p = 0.000). The area under the ROC curve for the A beta(40)/A beta(42) ratio was 0.76, and a cut-off ratio of 5.87 was suggested to have 70% sensitivity and 68% specificity. Conclusion: The plasma A beta(40)/A beta(42) ratio had moderate validity for the discrimination of sEOAD patients from age-matched controls.

키워드

Alzheimer's diseaseamyloid-beta proteinbiomarkerblood-brain barrierplasmaBLOOD-BRAIN-BARRIERMILD COGNITIVE IMPAIRMENTAMYLOID-BETA LEVELSCEREBROSPINAL-FLUIDRISKASSOCIATIONBIOMARKERSDEMENTIAPEPTIDEDECLINE

식별자

WoS UID
000363867300016